SCHEMBL21533852

SCHEMBL21533852

COc1cc(S)cc2c(C)ncnc12

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PDE5A O76074 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PIK3CA P42336 13/20 0.36
▸ PIK3R1 P27986 3/20 0.36
▸ HDAC1 Q13547 10/20 0.36
▸ PDE1B Q01064 2/20 0.33
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20813807 0.80 PDE5A (0.42) MEN1KMT2APDE5A
SCHEMBL24392596 0.79 PIK3CA (0.43) MEN1KMT2APDE5APIK3CAPIK3R1
SCHEMBL20350896 0.79 NQO2 (0.46) MEN1KMT2APDE5AALDH1A1MAPT
SCHEMBL12143431 0.75 PDE5A (0.68) PDE5APDE1B
SCHEMBL22745039 0.73 PIK3CA (0.48) PIK3CAPIK3R1HDAC1PIK3CDPIK3CB
SCHEMBL22745001 0.72 PIK3CA (0.42) PIK3CAPIK3R1HDAC1PIK3CDPIK3CB
SCHEMBL22744980 0.71 PIK3CA (0.53) PIK3CAPIK3R1HDAC1
SCHEMBL11583026 0.70 HTR1A (0.50) ALDH1A1
SCHEMBL22732354 0.70 PIK3CA (0.47) PIK3CAPIK3R1HDAC1PIK3CDPIK3CB
SCHEMBL13841363 0.70 PDE5A (0.42) MEN1KMT2APDE5AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560921-A1 QUINAZOLINE COMPOUND AND PREPARATION METHOD, APPLICATION, AND PHARMACEUTICAL COMPOSTION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2019-10-30 — — EP disclosed
Send feedback